Log In
BCIQ
Print this Print this
 

ADC-1015

  Manage Alerts
Collapse Summary General Information
Company Alligator Bioscience AB
DescriptionBispecific immune activating antibody targeting tumor necrosis factor (TNF) receptor superfamily member 4 (OX40;TNFRSF4; CD134) and cytotoxic T-lymphocyte associated protein 4 (CTLA4; CD152)
Molecular Target Tumor necrosis factor (TNF) receptor superfamily member 4 (OX40) (TNFRSF4) (CD134) ; Cytotoxic T-lymphocyte associated protein 4 (CTLA4) (CD152)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
PartnerBioInvent International AB

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/08/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today